Patrick Lee
Corporate Officer/Principal bei Steadfast Advisory Partners LLP
Profil
Patrick Lee is currently a Partner at Steadfast Advisory Partners LLP since 2009.
He has held several Director positions at Conatus Pharmaceuticals, Inc., Esaote SpA, Stallergenes SA, and Affidea Group BV.
He was also an Independent Director at Infinity Pharmaceuticals, Inc. from 2011 to 2013 and a Non-Executive Director at Axonics Women's Health Ltd.
He was a General Partner at Advent Venture Partners LLP and held a Group Vice President-Mergers & Acquisitions position at Rhone-Poulenc Rorer, Inc. and Rhone-Poulenc Rorer Pharmaceuticals, Inc. from 1989 to 1999.
He was also a Partner at Campus Holding SA from 2009 to 2015.
Mr. Lee holds an MBA from Stanford University, a graduate degree from The Johns Hopkins University, and an undergraduate degree from Vassar College.
Aktive Positionen von Patrick Lee
| Unternehmen | Position | Beginn |
|---|---|---|
| Steadfast Advisory Partners LLP | Corporate Officer/Principal | 01.02.2009 |
Ehemalige bekannte Positionen von Patrick Lee
| Unternehmen | Position | Ende |
|---|---|---|
Campus Holding SA
 Campus Holding SA Investment ManagersFinance Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland. | Private Equity Investor | 31.10.2015 |
| INFINITY PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 11.06.2013 |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01.06.2009 |
| Infinity Discovery, Inc. | Direktor/Vorstandsmitglied | 12.09.2006 |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | 01.01.1999 |
Ausbildung von Patrick Lee
| Vassar College | Undergraduate Degree |
| Stanford University | Masters Business Admin |
| The Johns Hopkins University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
Axonics Women's Health Ltd.
 Axonics Women's Health Ltd. Pharmaceuticals: MajorHealth Technology Contura Ltd. specializes in the distribution and sale of healthcare products, both in pharmaceuticals and medical devices. The firm focuses in the fields of urology and urogynaecology. Its products include bulkamid, cystistat, and aquamid. The company was founded by Henry Geoffrey McMillan in 2000 and is headquartered in London, the United Kingdom. | Health Technology |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
| Infinity Discovery, Inc. | |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Rhone-Poulenc Rorer, Inc.
 Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA. | Health Technology |
Campus Holding SA
Campus Holding SA Investment ManagersFinance Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland. | Finance |
Esaote SpA
 Esaote SpA Medical SpecialtiesHealth Technology Esaote SpA is a holding company, which engages in the production of medical diagnostic systems. Its products include ultrasound system applications, dedicated magnetic resonance imaging (MRI) systems, healthcare information technology software applications, and interventional and mini-invasive system applications under the brand name Esaote. The company was founded by Carlo Castellano in 1982 and is headquartered in Genoa, Italy. | Health Technology |
Affidea Group BV
 Affidea Group BV Medical/Nursing ServicesHealth Services Affidea Group BV provides diagnostic and renal care services. It is a medical service provider that offers diagnostic investigations, renal care, clinical laboratories, cancer treatment, and teleradiology services. The firm also operates centers for dialysis, diagnostic, and cancer treatment purposes. The company was founded in 1991 and is headquartered in Amsterdam, the Netherlands. | Health Services |
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
| Steadfast Advisory Partners LLP |
